EG vs KG: Side-by-Side Comparison
Compare Everest Group Ltd (EG) and KING PHARMACEUTICALS INC (KG) side by side: market cap USD 14.69B vs USD 79.49M, P/E 7.6 vs 0.9. Financials, growth and model signals on Bullrun.
| Metric | EG | KG |
|---|---|---|
| Company | Everest Group Ltd | KING PHARMACEUTICALS INC |
| Country / Exchange | Bermuda · NYSE | Bermuda · NASDAQ |
| Sector | Financial Services | Financial Services |
| Industry | Insurance-Reinsurance | Insurance-Reinsurance |
| Market cap | USD 14.69B | USD 79.49M |
| P/E ratio | 7.6 | 0.9 |
| Dividend yield | 1.08% | — |
| Valuation model | 32.5% undervalued | — |
| Revenue (FY2025) | USD 17.50B | USD 34.05M |
| Revenue growth YoY | +1.2% | +785.1% |
| Net income | USD 1.59B | USD 46.73M |
| Gross margin | — | — |
| Diluted EPS | 37.80 | 8.08 |